RxDoctor Payments Data

Patrick Colletti, MD

Nuclear Medicine · Los Angeles, CANPI 1578502639

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.2% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by GE HealthCare at 44.0% of the total. Reporting peaked in 2024 at $200 and has fallen 80.9% since, to $38 in 2025.

$578in general payments, 2019–2025

Across 20 payments — averaging $28.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GE HealthCare$254
  • Bayer$92
  • Siemens Medical Solutions USA, Inc.$79
  • Canon Medical Systems USA, Inc.$51
  • Progenics Pharmaceuticals, Inc.$49
  • Telix Pharmaceuticals$38
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$519%
  • Food & beverage$52891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GE HealthCare6$254
Bayer4$92
Siemens Medical Solutions USA, Inc.2$79
Canon Medical Systems USA, Inc.4$51
Progenics Pharmaceuticals, Inc.2$49
Telix Pharmaceuticals1$38
United Imaging Healthcare North America LLC1$15

How this compares

$578 in reported general payments places this provider in the 80th percentile of 110 nuclear medicine providers in California.

See all nuclear medicine providers in California

Medicare billing

Part B allowed, 2024
$48,436
Medicare patients
456
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →